Home › 2013 › October
Monthly Archives: October 2013
October 31, 2013

Dr Mitchell Glass to speak at breakfast presentation: Drugs & diagnostics – navigating the FDA approval chain

October 31, 2013

Appendix 4C – quarterly cashflow statement

October 29, 2013

MD & CEO, Dr Greg Collier, discusses the in-licence of INV104 (zafirlukast)

October 28, 2013

Invion enters into global licence agreement for inhaled zafirlukast: INV104

October 28, 2013

Corporate presentation – October 2013

October 22, 2013

Notice of Annual General Meeting

October 15, 2013

Change to composition of Executive

October 1, 2013

Change of registered office and principal place of business